SAN DIEGO, Aug. 21, 2017 — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that the State of Mexico’s government has purchased the company’s Real Scientific Hemp Oil-X™ (RSHO-X™) CBD...
[vc_row][vc_column][vc_column_text]Medical Marijuana, Inc. portfolio company HempMeds® just returned from Pittsburgh, Pennsylvania, where the company participated in the World Medical Cannabis Conference and Expo this past weekend. Hosted from Friday to Saturday,...
Medical Marijuana, Inc. VP of Operations and CEO of Kannaway Blake Schroeder appeared on CBS Pittsburgh radio with host Robert Mangino, ahead of Medical Marijuana, Inc.’s appearance at the World Medical Cannabis Conference and Expo this weekend. Blake touches on...
In order to fast-track approval of its new products, AXIM® Biotechnologies, Inc., a Medical Marijuana, Inc. investment company, has retained the services of Ora®, Inc. for the development of its cannabinoid-based eye treatments. A global Contract Research...
The following information is presented for educational purposes only. Medical Marijuana Inc. provides this information to provide an understanding of the potential applications of cannabidiol. Links to third party websites do not constitute an endorsement of these...
Article Also Details Company’s Pioneering Role in Latin America’s Burgeoning Cannabis Market SAN DIEGO, March 8, 2017 — Medical Marijuana, Inc. (OTC:MJNA) announced today that its subsidiary HempMeds® Mexico, the first company to receive government...
